Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Digestive Diseases and Sciences
|
August 1, 1996
Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man
G R Lipscomb, N Wallis, G Armstrong, et al.
Gut
|
February 1, 1991
Microscopic activity in ulcerative colitis: what does it mean?
S A Riley, V Mani, M J Goodman, et al.
Hawaii Medical Journal
|
May 1, 1982
Breast cancer screening in Hawaii 1974-1980: Results of a six-year program
M J Goodman, F I Gilbert, J S Grove, et al.
Lancet (London, England)
|
December 6, 1980
Campylobacter and Giardia lamblia causing exacerbation of inflammatory bowel disease
M J Goodman, K W Pearson, D McGhie, et al.
Surgical Forum
|
January 1, 1971
Hypophosphatemia with hypophosphaturia in hyperalimentation
R L Ruberg, T R Allen, M J Goodman, et al.
Gastroenterology
|
June 1, 1988
Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis
S A Riley, V Mani, M J Goodman, et al.
Gut
|
August 1, 1987
Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution
S A Riley, J Lecarpentier, V Mani, et al.
JAMA
|
May 4, 1984
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan
L S Goodman, M M Wintrobe, W Dameshek, et al.
Gut
|
May 1, 1988
Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse
S A Riley, V Mani, M J Goodman, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
February 3, 1999
Building health plan databases to risk adjust outcomes and payments
M C Hornbrook, M J Goodman, P A Fishman, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Digestive Diseases and Sciences
|
August 1, 1996
Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man
G R Lipscomb, N Wallis, G Armstrong, et al.
Gut
|
February 1, 1991
Microscopic activity in ulcerative colitis: what does it mean?
S A Riley, V Mani, M J Goodman, et al.
Hawaii Medical Journal
|
May 1, 1982
Breast cancer screening in Hawaii 1974-1980: Results of a six-year program
M J Goodman, F I Gilbert, J S Grove, et al.
Lancet (London, England)
|
December 6, 1980
Campylobacter and Giardia lamblia causing exacerbation of inflammatory bowel disease
M J Goodman, K W Pearson, D McGhie, et al.
Surgical Forum
|
January 1, 1971
Hypophosphatemia with hypophosphaturia in hyperalimentation
R L Ruberg, T R Allen, M J Goodman, et al.
Gastroenterology
|
June 1, 1988
Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis
S A Riley, V Mani, M J Goodman, et al.
Gut
|
August 1, 1987
Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution
S A Riley, J Lecarpentier, V Mani, et al.
JAMA
|
May 4, 1984
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan
L S Goodman, M M Wintrobe, W Dameshek, et al.
Gut
|
May 1, 1988
Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse
S A Riley, V Mani, M J Goodman, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
February 3, 1999
Building health plan databases to risk adjust outcomes and payments
M C Hornbrook, M J Goodman, P A Fishman, et al.
Page
of 9